Late-Stage C(sp 2)–C(sp 3) Diversification via Nickel Oxidative Addition Complexes

Herein, we describe nickel oxidative addition complexes (Ni-OACs) of drug-like molecules as a platform to rapidly generate lead candidates with enhanced C(sp 3) fraction. The potential of Ni-OACs to access new chemical space has been assessed not only in C(sp 2)–C(sp 3) couplings but also in addi...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of the American Chemical Society Vol. 146; no. 31; pp. 21264 - 21270
Main Authors:	Odena, Carlota, Santiago, Tomás G., Linares, María Lourdes, Castellanos-Blanco, Nahury, McGuire, Ryan T., Chaves-Arquero, Belén, Alonso, Jose Manuel, Diéguez-Vázquez, Alejandro, Tan, Eric, Alcázar, Jesús, Buijnsters, Peter, Cañellas, Santiago, Martin, Ruben
Format:	Journal Article
Language:	English
Published:	United States American Chemical Society 07-08-2024
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Herein, we describe nickel oxidative addition complexes (Ni-OACs) of drug-like molecules as a platform to rapidly generate lead candidates with enhanced C(sp 3) fraction. The potential of Ni-OACs to access new chemical space has been assessed not only in C(sp 2)–C(sp 3) couplings but also in additional bond formations without recourse to specialized ligands and with improved generality when compared to Ni-catalyzed reactions. The development of an automated diversification process further illustrates the robustness of Ni-OACs, thus offering a new gateway to expedite the design–make–test–analyze (DMTA) cycle in drug discovery.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0002-7863 1520-5126 1520-5126
DOI:	10.1021/jacs.4c08404